Total Liabilities (Quarterly) Chart

View Total Liabilities (Quarterly) for MAJI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Liabilities (Quarterly) Chart
Start Trial

Historical Total Liabilities (Quarterly) Data

View and export this data back to 2010. Start Trial.
Date Value
June 30, 2026 0.873M
March 31, 2026 0.985M
September 30, 2025 0.6768M
June 30, 2025 0.7212M
March 31, 2025 0.8779M
October 31, 2024 0.0541M
July 31, 2024 0.0541M
April 30, 2024 0.0533M
January 31, 2024 0.0533M
October 31, 2023 0.1156M
July 31, 2023 0.1081M
April 30, 2023 0.0493M
January 31, 2023 0.032M
October 31, 2022 0.0251M
July 31, 2022 0.0047M
April 30, 2022 0.0042M
January 31, 2022 0.00
October 31, 2021 0.4448M
July 31, 2021 0.4448M
April 30, 2021 0.1609M
January 31, 2021 0.4448M
October 31, 2020 0.4448M
July 31, 2020 0.4643M
April 30, 2020 0.4448M
January 31, 2020 0.2187M
Date Value
October 31, 2019 0.0417M
July 31, 2019 0.011M
April 30, 2019 0.2143M
January 31, 2019 0.1711M
October 31, 2018 0.1443M
July 31, 2018
April 30, 2018
January 31, 2018
October 31, 2017
July 31, 2017
April 30, 2017
January 31, 2017
October 31, 2016
July 31, 2016
April 30, 2016
January 31, 2016
October 31, 2015
July 31, 2015
April 30, 2015
January 31, 2015
October 31, 2014
July 31, 2014
April 30, 2014
January 31, 2014
October 31, 2013

Total Liabilities Definition

Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.

Read full definition.

Total Liabilities (Quarterly) Range, Past 5 Years

View Total Liabilities (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Liabilities (Quarterly) Benchmarks

View Total Liabilities (Quarterly) Benchmarks
Start Trial
Myriad Genetics, Inc. 335.00M
BioRestorative Therapies, Inc. 1.615M
Astrana Health, Inc. 1.684B
U.S. Stem Cell, Inc. --
CareDx, Inc. 107.39M

Total Liabilities (Quarterly) Related Metrics